The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex
Open accessAbstract
Microarray expression profiling of prefrontal cortex from matched pairs of schizophrenic and control subjects and hierarchical data analysis revealed that transcripts encoding proteins involved in the regulation of presynaptic function (PSYN) were decreased in all subjects with schizophrenia. Genes of the PSYN group showed a different combination of decreased expression across subjects. Over 250 other gene groups did not show altered expression. Selected PSYN microarray observations were verified by in situ hybridization. Two of the most consistently changed transcripts in the PSYN functional gene group, N-ethylmaleimide sensitive factor and synapsin II, were decreased in ten of ten and nine of ten subjects with schizophrenia, respectively. The combined data suggest that subjects with schizophrenia share a common abnormality in presynaptic function. We set forth a predictive, testable model.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our observation that the degree of correlation between pathways across disorders is higher than expected by chance builds on the observation of shared genetics between these disorders4 and, importantly, indicates that polygenic overlap is nonrandom at a molecular or pathway level.”
From Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways (2015) · cites this paper as [4]
Citations
Cites
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Self-citationSynaptic density in human frontal cortex —Developmental changes and effects of aging
Peter R., H. (1979) · Brain Research · doi:10.1016/0006-8993(79)90349-4 · Cited by 2,645
Exploring the new world of the genome with DNA microarrays
Brown, P. O., & Botstein, D. (1999) · Nature Genetics · doi:10.1038/4462 · Cited by 2,430
Physiologic Dysfunction of Dorsolateral Prefrontal Cortex in Schizophrenia
Weinberger, D. R. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020020004 · Cited by 2,025
The synaptic vesicle cycle: a cascade of protein–protein interactions
Südhof, T. C. (1995) · Nature · doi:10.1038/375645a0 · Cited by 1,991
Searching for genetic determinants in the new millennium
Risch, N. J. (2000) · Nature · doi:10.1038/35015718 · Cited by 1,839
The neuropathology of schizophrenia
Harrison, P. J. (1999) · Brain · doi:10.1093/brain/122.4.593 · Cited by 1,677
Expression profiling using cDNA microarrays
Duggan, D. J., Bittner, M. L., Chen, Y., Meltzer, P. S., & Trent, J. M. (1999) · Nature Genetics · doi:10.1038/4434 · Cited by 1,660
Decreased Dendritic Spine Density on Prefrontal Cortical Pyramidal Neurons in Schizophrenia
Glantz, L. A., & Lewis, D. A. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.1.65 · Cited by 1,636
Self-citation
Research works printed but not linked: 3
- Lewis, 2000, Catching up with schizophrenia, Neuron, in press
- Volk, 2000, Decreased GAD67 mRNA expression in a subset of prefrontal cortical GABA neurons in schizophrenia, Arch. Gen. Psychiatry, in press
- Weinberger, 1999, Schizophrenia, Biol. Psychiatry, 46, 3
Cited by
Sorted by citations
Items 101–200 of 880
Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia
Weickert, C. S., Ligons, D. L., Romanczyk, T. B., Ungaro, G., Hyde, T. M., Herman, M. M., Weinberger, D. R., & Kleinman, J. E. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001678 · Cited by 199
Patterns of gene expression in the limbic system of suicides with and without major depression
Sequeira, A., Klempan, T. A., Canetti, L., ffrench-Mullen, J. M. H., Benkelfat, C., Rouleau, G. A., & Turecki, G. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001969 · Cited by 200
Costa, E., Davis, J. M., Grayson, D. R., Guidotti, A., Pappas, G. D., & Pesold, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0436 · Cited by 197
The GABA-glutamate connection in schizophrenia: which is the proximate cause?
Coyle, J. T. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.07.034 · Cited by 194
Hwang, Y., Kim, J., Shin, J.-Y., Kim, J.-I., Seo, J.-S., Webster, M. J., Lee, D., & Kim, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.94 · Cited by 189
Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia
Vawter, M. P., Thatcher, L. N., Usen, N., Hyde, T. M., Kleinman, J. E., & Freed, W. J. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001158 · Cited by 188
Genetic factors influencing alcohol dependence
Mayfield, R. D., Harris, R. A., & Schuckit, M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.88 · Cited by 186
Jiménez-Baladó, J., & Eich, T. S. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.01.005 · Cited by 194
Alméras, L., Eyles, D. W., Benech, P. D., Laffite, D., Villard, C., Patatian, A., Boucraut, J., Mackay‐Sim, A., McGrath, J. J., & Feron, F. P. (2007) · PROTEOMICS · doi:10.1002/pmic.200600392 · Cited by 186
Mutch, S. A., Kensel-Hammes, P., Gadd, J. C., Fujimoto, B. S., Allen, R. W., Schiro, P. G., Lorenz, R. M., Kuyper, C. L., Kuo, J. S., Bajjalieh, S. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-10.2011 · Cited by 185
Thompson, M., Weickert, C. S., Wyatt, E. J., & Webster, M. J. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2009.02.005 · Cited by 193
GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies
de Jonge, J. C., Vinkers, C. H., Pol, H. E. H., & Marsman, A. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00118 · Cited by 203
Eyles, D. W., Alméras, L., Benech, P. D., Patatian, A., Mackay‐Sim, A., McGrath, J. J., & Feron, F. P. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.096 · Cited by 179
Extracellular matrix abnormalities in schizophrenia
Berretta, S. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.010 · Cited by 179
Immune System Disturbances in Schizophrenia
Horváth, S., & Mirnics, K. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.010 · Cited by 181
Self-citationMartins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Maccarrone, G., Hunyadi‐Gulyás, É., Eberlin, M. N., Souza, G. H. M. F., Marangoni, S., Novello, J. C., Turck, C. W., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.11.006 · Cited by 176
Calcium signaling dysfunction in schizophrenia: a unifying approach
Lidow, M. S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00203-0 · Cited by 174
Rao, V. L. R., Bowen, K. K., Dhodda, V. K., Song, G., Franklin, J. L., Gavva, N. R., & Dempsey, R. J. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01208.x · Cited by 173
Microarray reality checks in the context of a complex disease
Miklos, G. L. G., & Maleszka, R. (2004) · Nature Biotechnology · doi:10.1038/nbt965 · Cited by 176
Functional genomics to new drug targets
Kramer, R. S., & Cohen, D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1552 · Cited by 169
Murray, A., Wołoszynowska-Fraser, M. U., Ansel-Bollepalli, L., Marshall-Phelps, K. L., Foggetti, A., Crouch, B., Riedel, G., & Wulff, P. (2015) · Scientific Reports · doi:10.1038/srep16778 · Cited by 173
The Synaptic Hypothesis of Schizophrenia
Frankle, W. G., Lerma, J., & Laruelle, M. A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00423-9 · Cited by 172
Burns, J. K. (2004) · Behavioral and Brain Sciences · doi:10.1017/s0140525x04000196 · Cited by 171
Ray, M. T., Shannon Weickert, C., & Webster, M. J. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.26 · Cited by 161
Tau haplotypes regulate transcription and are associated with Parkinson's disease
Kwok, J. B., Teber, E., Loy, C. T., Hallupp, M., Nicholson, G. A., Mellick, G. D., Buchanan, D. D., Silburn, P. A., & Schofield, P. R. (2004) · Annals of Neurology · doi:10.1002/ana.10826 · Cited by 159
The problem of neuronal cell types: a physiological genomics approach
Nelson, S. B., Sugino, K., & Hempel, C. M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.004 · Cited by 157
A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia
Clark, D., Dedova, I. V., Cordwell, S. J., & Matsumoto, I. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001806 · Cited by 153
A comprehensive analysis of 22q11 gene expression in the developing and adult brain
Maynard, T. M., Haskell, G., Peters, A. Z., Sikich, L., Lieberman, J. A., & LaMantia, A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235651100 · Cited by 155
Pantazopoulos, H., Markota, M., Jaquet, F., Ghosh, D., Wallin, A., Santos, A., Caterson, B., & Berretta, S. (2015) · Translational Psychiatry · doi:10.1038/tp.2014.128 · Cited by 153
Fatemi, S. H., Pearce, D. A., Brooks, A. I., & Sidwell, R. W. (2005) · Synapse · doi:10.1002/syn.20162 · Cited by 151
Progress in the use of microarray technology to study the neurobiology of disease
Mirnics, K., & Pevsner, J. (2004) · Nature Neuroscience · doi:10.1038/nn1230 · Cited by 150
Self-citationAbnormalities of SNARE Mechanism Proteins in Anterior Frontal Cortex in Severe Mental Illness
Honer, W. G. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.4.349 · Cited by 149
CARMEL, J. B., GALANTE, A., SOTEROPOULOS, P., TOLIAS, P., RECCE, M., YOUNG, W., & HART, R. P. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.00074.2001 · Cited by 121
GeneChip ® analysis after acute spinal cord injury in rat
Song, G., Cechvala, C., Resnick, D. K., Dempsey, R. J., & Rao, V. L. R. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00626.x · Cited by 147
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Rewerts, C., Marangoni, S., Novello, J. C., Maccarrone, G., Turck, C. W., & Dias‐Neto, E. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0156-y · Cited by 146
Glutamate Dysfunction in Hippocampus: Relevance of Dentate Gyrus and CA3 Signaling
Tamminga, C. A., Southcott, S. A., Sacco, C., Wagner, A. D., & Ghose, S. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs062 · Cited by 152
Martins‐de‐Souza, D., Gattaz, W. F., Schmitt, A., Novello, J. C., Marangoni, S., Turck, C. W., & Dias‐Neto, E. (2009) · BMC Psychiatry · doi:10.1186/1471-244x-9-17 · Cited by 144
Elliott, R. C., Miles, M. F., & Lowenstein, D. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02218.2003 · Cited by 143
Eastwood, S. L., Law, A. J., Everall, I., & Harrison, P. J. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001233 · Cited by 145
Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia
Schmidt‐Kastner, R., van Os, J., Steinbusch, H. W. M., & Schmitz, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.02.022 · Cited by 146
Target Identification for CNS Diseases by Transcriptional Profiling
Altar, C. A., Vawter, M. P., & Ginsberg, S. D. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.172 · Cited by 139
SNARE-complex disassembly by NSF follows synaptic-vesicle fusion
Littleton, J. T., Barnard, R. J. O., Titus, S. A., Slind, J., Chapman, E. R., & Ganetzky, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221450198 · Cited by 140
Akbarian, S., Ruehl, M. G., Bliven, E. E., Luiz, L. A., Peranelli, A. C., Baker, S. P., Roberts, R. C., Bunney, W. E., Conley, R. C., Jones, E. G., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.829 · Cited by 140
Critical Appraisal of DNA Microarrays in Psychiatric Genomics
Mirnics, K., Levitt, P. R., & Lewis, D. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.003 · Cited by 139
Self-citationDisease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders
Tang, B., Dean, B., & Thomas, E. A. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.61 · Cited by 137
Jaaro-Peled, H., Ayhan, Y., Pletnikov, M. V., & Sawa, A. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp133 · Cited by 144
Neuronal and non-neuronal functions of the AP-3 sorting machinery
Litwa, K., Seong, E., Burmeister, M., & Faúndez, V. (2007) · Journal of Cell Science · doi:10.1242/jcs.03365 · Cited by 137
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 138
Variations in differential gene expression patterns across multiple brain regions in schizophrenia
Katsel, P., Davis, K. L., Gorman, J. M., & Haroutunian, V. H. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.03.020 · Cited by 135
Genetic investigation of chromosome 5q GABAA receptor subunit genes in schizophrenia
Petryshen, T. L., Middleton, F. A., Tahl, A. R., Rockwell, G. N., Purcell, S., Aldinger, K. A., Kirby, A. W., Morley, C. P., McGann, L., Gentile, K. L., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001739 · Cited by 132
Self-citationStraub, R. E., MacLean, C. J., Ma, Y., Webb, B. T., Myakishev, M. V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B., O’Neill, F. A., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001051 · Cited by 133
Neurodevelopment, neuroplasticity, and new genes for schizophrenia
Arnold, S. E., Talbot, K., & Hahn, C.-G. (2004) · Progress in brain research · doi:10.1016/s0079-6123(04)47023-x · Cited by 135
Bunney, W. E., Bunney, B. G., Vawter, M. P., Tomita, H., Li, J. Z., Evans, S. J., Choudary, P. V., Myers, R., Jones, E. G., Watson, S. J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.657 · Cited by 130
Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree
Vawter, M. P. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)00151-8 · Cited by 132
Albertson, D. N., Schmidt, C. J., Kapatos, G., & Bannon, M. J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301089 · Cited by 128
Synaptic changes in the brain of subjects with schizophrenia
Faludi, G., & Mirnics, K. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.02.013 · Cited by 131
Self-citationWalterfang, M., Wood, S. J., Velakoulis, D., & Pantelis, C. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.02.001 · Cited by 131
BLOC-1 Complex Deficiency Alters the Targeting of Adaptor Protein Complex-3 Cargoes
Salazar, G., Craige, B., Styers, M. L., Litwa, K., Doucette, M. M., Wainer, B. H., Falcón‐Pérez, J. M., Dell’Angelica, E. C., Peden, A. A., Werner, E., et al. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-02-0103 · Cited by 131
Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility
Dutton, S. B., Makinson, C. D., Papale, L. A., Shankar, A., Balakrishnan, B., Nakazawa, K., & Escayg, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.012 · Cited by 128
Schizophrenia: susceptibility genes, dendritic-spine pathology and gray matter loss
Bennett, M. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.003 · Cited by 129
The structure of the tau haplotype in controls and in progressive supranuclear palsy
Pittman, A. M. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh138 · Cited by 127
Kinnunen, A., Koenig, J. I., & Bilbe, G. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01873.x · Cited by 127
Kim, S., & Webster, M. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.99 · Cited by 102
Charych, E. I., Liu, F., Moss, S. J., & Brandon, N. J. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.027 · Cited by 130
Liu, J., Lewohl, J. M., Dodd, P. R., Randall, P. K., Harris, R. A., & Mayfield, R. D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02570.x · Cited by 127
Nascimento, J. M., & Martins‐de‐Souza, D. (2015) · Schizophrenia · doi:10.1038/npjschz.2014.3 · Cited by 125
Carter, C. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.05.023 · Cited by 127
Fatemi, S. H., Folsom, T. D., Rooney, R. J., & THURAS, P. D. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.64 · Cited by 125
Halim, N. D., Weickert, C. S., McClintock, B. W., Hyde, T. M., Weinberger, D. R., Kleinman, J. E., & Lipska, B. K. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001319 · Cited by 124
Gene Expression Profiling of Depression and Suicide in Human Prefrontal Cortex
Sibille, E. L., Arango, V., Galfalvy, H., Pavlidis, P., Erraji-Benchekroun, L., Ellis, S., & Mann, J. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300335 · Cited by 126
Animal models of obstetric complications in relation to schizophrenia
Boksa, P. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.01.001 · Cited by 125
The Role of Synapsins in Neurological Disorders
Mirza, F. J., & Zahid, S. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0201-7 · Cited by 127
SNAP-25 reduction in the hippocampus of patients with schizophrenia
Thompson, P. M., Egbufoama, S., & Vawter, M. P. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(03)00027-7 · Cited by 122
Kostović, I., Judáš, M., & Sedmak, G. (2010) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.09.005 · Cited by 122
Differential Gene Expression Patterns Revealed by Oligonucleotide Versus Long cDNA Arrays
Li, J. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.2.383 · Cited by 121
Lamina-Specific Alterations in Cortical GABAA Receptor Subunit Expression in Schizophrenia
Beneyto, M., Abbott, A., Hashimoto, T., & Lewis, D. A. (2010) · Cerebral Cortex · doi:10.1093/cercor/bhq169 · Cited by 121
Self-citationSchizophrenia: New Pathological Insights and Therapies
Jarskog, L. F., Miyamoto, S., & Lieberman, J. A. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.060904.084114 · Cited by 119
Mash, D. C., ffrench‐Mullen, J. M. H., Adi, N., Qin, Y., Buck, A., & Pablo, J. P. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001187 · Cited by 119
A new hypothesis of drug refractory epilepsy: Neural network hypothesis
Fang, M., Xi, Z., Wu, Y. F., & Wang, X. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.02.039 · Cited by 118
Mudge, J., Miller, N., Khrebtukova, I., Lindquist, I. E., May, G. D., Huntley, J. J., Luo, S. J., Zhang, L., van Velkinburgh, J. C., Farmer, A. D., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003625 · Cited by 120
Middleton, F. A., Pato, C. N., Gentile, K. L., McGann, L., Brown, A. M., Trauzzi, M., Diab, H. I., Morley, C. P., Medeiros, H., Macedo, A., et al. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30171 · Cited by 116
Self-citationEvaluation of Affymetrix Gene Chip sensitivity in rat hippocampal tissue using SAGE analysis*
Evans, S. J., Datson, N. A., Kabbaj, M., Thompson, R. C., Vreugdenhil, E., de Kloet, E. R., Watson, S. J., & Akil, H. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02097.x · Cited by 116
Sugai, T., Kawamura, M., Iritani, S., Araki, K., Makifuchi, T., Imai, C., Nakamura, R., Kakita, A., Takahashi, H., & Nawa, H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.011 · Cited by 115
Brain, blood, cerebrospinal fluid, and serum biomarkers in schizophrenia
Mohammadi, A., Rashidi, E., & Amooeian, V. G. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.04.036 · Cited by 119
Hippocampal Complexin Proteins and Cognitive Dysfunction in Schizophrenia
Sawada, K., Barr, A. M., Nakamura, M., Arima, K., Young, C. E., Dwork, A. J., Falkai, P., Phillips, A. G., & Honer, W. G. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.3.263 · Cited by 115
Beneyto, M., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20329 · Cited by 113
A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene
Zhu, Y., Kalbfleisch, T., Brennan, M. D., & Li, Y. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.022 · Cited by 114
A microarray study of post-mortem mRNA degradation in mouse brain tissue
Catts, V. S., Catts, S. V., Fernandez, H. R., Taylor, J. M., Coulson, E. J., & Lutze-Mann, L. H. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2005.04.017 · Cited by 113
Altered Cortical Glutamate Neurotransmission in Schizophrenia
Lewis, D. A., Glantz, L. A., Pierri, J. N., & Sweet, R. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.007 · Cited by 113
Self-citationPostmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador‐Woodruff, J. H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.239 · Cited by 115
Synapsin-I- and synapsin-II-null mice display an increased age-dependent cognitive impairment
Corradi, A. M., Zanardi, A., Giacomini, C., Onofri, F., Valtorta, F., Zoli, M., & Benfenati, F. (2008) · Journal of Cell Science · doi:10.1242/jcs.035063 · Cited by 113
Pasinetti, G. M. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1176 · Cited by 111
Predicting Drug Efficacy for Cognitive Deficits in Schizophrenia
Hagan, J. J. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi058 · Cited by 111
The limitations of simple gene set enrichment analysis assuming gene independence
Tamayo, P., Steinhardt, G., Liberzon, A., & Mesirov, J. P. (2012) · Statistical Methods in Medical Research · doi:10.1177/0962280212460441 · Cited by 109
Theranostic Biomarkers for Schizophrenia
Perković, M. N., Erjavec, G. N., Štrac, D. Š., Uzun, S., Kozumplik, O., & Pivac, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040733 · Cited by 113
Prefrontal Cortical Circuits in Schizophrenia
Volk, D. W., & Lewis, D. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_44 · Cited by 107
Self-citationLongitudinal Brain Changes in Early-Onset Psychosis
Arango, C., Moreno, C., Martı́nez, S., Parellada, M., Desco, M., Moreno, D. M., Fraguas, D., Gogtay, N., James, A. C., & Rapoport, J. L. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbm157 · Cited by 110
Cortical Oscillations in Health and Disease
Traub, R. D., & Whittington, M. A. (2010) · doi:10.1093/acprof:oso/9780195342796.001.0001 · Cited by 108
Gene Expression Profiling with DNA Microarrays: Advancing Our Understanding of Psychiatric Disorders
Pongrac, J. L., Middleton, F. A., Lewis, D. A., Levitt, P. R., & Mirnics, K. (2002) · Neurochemical Research · doi:10.1023/a:1020904821237 · Cited by 107
Self-citationDefects in Bioenergetic Coupling in Schizophrenia
Sullivan, C. R., O'Donovan, S. M., McCullumsmith, R. E., & Ramsey, A. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.014 · Cited by 108
Metadata
- Authors
- Mirnics, K., Middleton, F. A., Marquez, A., Lewis, D. A., & Levitt, P.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Mirnics, Károly
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2000-10
- Volume
- 28
- Issue
- 1
- Pages
- 53-67
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2032208151
- Cited by
- 882
- References
- 105
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 13 · 2018: 16 · 2017: 14 · 2016: 19 · 2015: 32 · 2014: 19 · 2013: 29 · 2012: 37
- FWCI
- 48.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Neuron (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (T32 MH18273, MH 45156, T32MH018273, P50MH045156)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- schizophrenia, prefrontal cortex, gene expression profiling, presynaptic function, N-ethylmaleimide-sensitive factor, synapsin II, transcriptome
- MeSH terms
- Animals, Carrier Proteins, Female, Humans, Macaca fascicularis, Male, Middle Aged, Synaptic Transmission, RNA, Messenger, Schizophrenia, Synapses, Antipsychotic Agents, Genetic Variation, Gene Expression, Confounding Factors, Epidemiologic, Synapsins, Prefrontal Cortex, In Situ Hybridization, Presynaptic Terminals, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Vesicular Transport Proteins, N-Ethylmaleimide-Sensitive Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review